Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Quest Diagnostics (DGX)

Quest Diagnostics 2025 adjusted EPS up 10.3% to $9.85; 2026 guidance issued

Positive Impact 4 of 5 earnings Written later

Quest Diagnostics reported fourth-quarter and full-year 2025 results with double-digit full-year growth in revenue and EPS, and issued 2026 guidance for net revenues of $11.70 billion to $11.82 billion. The board also raised the quarterly dividend 7.5% to $0.86 per share and added $1 billion to its share repurchase authorization, which matters to shareholders because it increases cash returned to them.

Key points

  • Full-year 2025 net revenues were $11.04 billion, up 11.8%, and reported diluted EPS was $8.75, up 13.8%.
  • Fourth-quarter revenues were $2.81 billion, up 7.1%, and adjusted diluted EPS was $2.42, up 8.5%.
  • 2026 guidance: reported diluted EPS of $9.45 to $9.65 and adjusted diluted EPS of $10.50 to $10.70.
  • Quarterly dividend rises from $0.80 to $0.86 per share, payable April 20, 2026 to holders of record on April 6, 2026; repurchase authorization increased by $1 billion.

The filing

CompanyQuest Diagnostics (DGX)
Form8-K, current report
Filed with the SECFeb 10, 2026, 6:53 AM ET
Accession number0001022079-26-000005

Items reported: 2.02 Results of Operations8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:10 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 10, 2026.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.